Skip to content
Review

Immunomodulatory mechanisms of bile acids in autoimmune diseases along the gut-liver axis.

Sep 2026 · Autoimmunity Reviews · Vol 25, pp. 104183 · 0 citations
Medicine

TL;DR

The immune-regulatory network of BAs, which includes both receptor-dependent pathways and receptor-independent mechanisms, is examined, and emerging therapeutic strategies aimed at restoring metabolic-immune homeostasis are assessed.

View source

Similar papers

Review Sep 2026

The gastrointestinal pathway leading to autoimmune diseases.

This review explores the key gastrointestinal pathways linking microbiota alterations to immune dysregulation, emphasizing mechanisms that operate from extracellular barrier function to intracellular signaling cascades.

Daniel Martins Vieira Zimmermann, Daniela Diamantino, Samuel de Oliveira Andrade et al. · 0 citations
Review Open access Aug 2026

The gut microbiota-tryptophan metabolism-immune axis in inflammatory bowel disease: Mechanisms and therapeutic prospects

ABSTRACT The gut microbiota–tryptophan (TRP) metabolism–immune axis is one of the core pathogenic mechanisms in inflammatory bowel disease (IBD). Physiologically, gut microbes convert dietary TRP into bioactive metabolites that regulate intestinal immune balance and barrier function via AHR. In IBD, this axis enters a...

Teng-Fei Wang, Xiao-Gan Wang, Wei-Chen Yuan · 0 citations
Review Open access Oct 2026

Crosstalk between gut microbiota-associated metabolites and adaptive immunity in cholecystitis: a conceptual mechanistic framework and potential therapeutic implications

The pathogenesis of cholecystitis involves the complex interplay of bile stasis, microbial dysbiosis, metabolic disturbances, and immune responses. Gut microbiota-associated metabolites can modulate adaptive immune components, including T helper 17 (Th17) cells, regulatory T (Treg) cells, CD8+ T cells, and B cells, thr...

Xin-Qi Wang, Tao Zhang, Zhe-Tan Ren et al. · 0 citations
Review Open access Oct 2026

Microbiological mechanisms of immune response modulation: clinical implications

The human microbiota is a major regulator of immune development, mucosal barrier integrity, and systemic immune tone. Its effects are mediated by microbe-associated molecular patterns, pattern-recognition receptors, microbial metabolites such as short-chain fatty acids, tryptophan-derived indoles, secondary bile acids...

A. Deptuła, Aleksandra Ćwirko-Godycka, A. Majcherczak et al. · 0 citations
Review Open access Oct 2026

Gut microbiota-bile acid-immune axis: receptor signaling, metabolic regulation, and therapeutic translation

This review comprehensively summarizes the molecular mechanisms, receptor signaling pathways, metabolic regulation, and clinical translational potential of this axis, aiming to provide theoretical support for future precision medicine and innovative therapeutic strategies.

Rui He, Qiang-Qiang Zheng, Yi Shen · 0 citations
Review Open access Oct 2026

Reframing the gut-lung axis: Microbiota dysbiosis, immune-redox regulation, and the potential role of vitamin C.

The respiratory system is continuously exposed to environmental antigens, pathogens, and pollutants, requiring tightly regulated immunity to balance inflammation and host defense. Increasing evidence indicates that the microbiome-within the airways and through the gut-lung axis-plays a critical role in shaping pulmonar...

Lunawati L. Bennett · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.